Results 271 to 280 of about 1,044,820 (327)
Peptide Display Directed Assembly of Biopolymer Core–Silica Shell Particles
Bacterial cells are engineered to produce biopolyester particles displaying peptides mediating growth of silica. Peptide‐coated biopolyester particles are treated with silica precursors and silica shell formation is studied. Transmission electron microscopy shows silica‐coated BPs which are formed after the silicification treatment. Characterization of
Deeptee Chandrashekhar Pande+2 more
wiley +1 more source
RETRACTION: Calycosin Inhibits Hepatocyte Apoptosis in Acute Liver Failure by Suppressing the TLR4/NF-κB Pathway: An In Vitro Study. [PDF]
europepmc +1 more source
LPS promotes the production of ROS in neutrophils to regulate their killing activity against Mycobacterium tuberculosis. [PDF]
Jiang L, Su Z, Zhang Y, Liu H, Wang H.
europepmc +1 more source
A novel dissolving microneedle platform preserves HPV virus‐like particle (VLP) immunogenicity by maintaining structural integrity, crucial for eliciting potent immune responses. Buccal administration induces robust immune response, high neutralizing antibody titers, and durable sterile protection across oral and vaginal mucosal sites.
Hyemi Kim+12 more
wiley +1 more source
A Neutrophil Storage Pool in the Fetal Liver is the Principal Source of the Postnatal Neutrophil Surge. [PDF]
Ishiwata R, Morimoto Y.
europepmc +1 more source
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail+3 more
wiley +1 more source
p38 mitogen-activated protein kinase drives senescence in CD4<sup>+</sup> T lymphocytes and increases their pathological potential. [PDF]
González-Osuna L+8 more
europepmc +1 more source
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision
Advancements in ART improve HIV‐1 patient outcomes but are unable to eliminate latent viral DNA. To address this, CXCR4‐targeted lipid nanoparticles (T‐LNPs) for delivering CRISPR‐Cas9 to excise HIV‐1 DNA in infected cells are developed. These T‐LNPs achieve ≈60% HIV‐1 DNA excision efficacy in blood and splenic tissue, demonstrating promise for ...
Sudipta Panja+6 more
wiley +1 more source